EasyCardiologyAnticoagulation strategy in atrial fibrillationau-amcau-racp
A 76-year-old man with non-valvular atrial fibrillation and a CHA₂DS₂-VA score of 3 has been stable on warfarin for several years with therapeutic INR 2.0-3.0. He has no history of major bleeding. According to Australian AF and stroke prevention guidelines, what is the most appropriate ongoing antithrombotic strategy?